drug
as of 2026-07-01PP3M 263 mg eq.
at a glance
small molecule
Pre-approval / investigational in the US
2 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
2
Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Patients With Schizophrenia
NCT01515423Phase 3Completed
A Study of Paliperidone Palmitate 3 Month Formulation for the Treatment of Patients With Schizophrenia
NCT01529515Phase 3Completed
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
trial
indication
indication
indication